pretreatment of the human k562 leukemia and hhms melanoma with ifn-gamma and the daudi lymphoma with ifn-alpha caused a significant reduction in sensitivity to lysis by human lak cells generated in vitro in the presence of human recombinant il-2 ( 100 u/ml ) .
C0025202
ifn-gamma
C0218986
human recombinant